Fig. 1

Time course of disease activity scores over 24 weeks of tofacitinib and baricitinib treatments. Points and bars represent means and standard deviations, respectively. ^*,†P < 0.0001 vs baseline by the Wilcoxon signed rank test. ESR erythrocyte sedimentation rate, DAS disease activity score